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Abstract
Background: Hospital admissions for heart failure are predicted to rise substantially over the next decade placing
increasing pressure on the health care system. There is an urgent need to redesign systems of care for heart failure
to improve evidence-based practice and create seamless transitions through the continuum of care. The aim of the
review was to examine systems of care for heart failure that reduce hospital readmissions and/or mortality.
Method: Electronic databases searched were: Ovid MEDLINE, EMBASE, CINAHL, grey literature, reviewed
bibliographies and Cochrane Central Register of Controlled Trials for randomised controlled trials, non-randomised
trials and cohort studies from 1st January 2008 to 4th August 2015. Inclusion criteria for studies were: English
language, randomised controlled trials, non-randomised trials and cohort studies of systems of care for patients
diagnosed with heart failure and aimed at reducing hospital readmissions and/or mortality.
Three reviewer authors independently assessed articles for eligibility based on title and abstract and then full-text.
Quality of evidence was assessed using Newcastle-Ottawa Scale for non-randomised trials and GRADE rating tool
for randomised controlled trials.
Results: We included 29 articles reporting on systems of care in the workforce, primary care, in-hospital, transitional
care, outpatients and telemonitoring. Several studies found that access to a specialist heart failure team/service
reduced hospital readmissions and mortality. In primary care, a collaborative model of care where the primary
physician shared the care with a cardiologist, improved patient outcomes compared to a primary physician only.
During hospitalisation, quality improvement programs improved the quality of inpatient care resulting in reduced
hospital readmissions and mortality. In the transitional care phase, heart failure programs, nurse-led clinics, and early
outpatient follow-up reduced hospital readmissions. There was a lack of evidence as to the efficacy of
telemonitoring with many studies finding conflicting evidence.
Conclusion: Redesigning systems of care aimed at improving the translation of evidence into clinical practice and
transitional care can potentially improve patient outcomes in a cohort of patients known for high readmission rates
and mortality.
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Background
Approximately 1–3 % of the adult population have been
diagnosed with heart and one in five people will develop
heart failure during their lifetime with the incidence
increasing with age [1]. The prognosis of heart failure is
poor with a 10 % in-hospital mortality rate from acute heart
failure, post-discharge 20–40 % mortality rate within one
year, and 20–25 % will be readmitted within one month
[2–7]. Over the natural course of heart failure, people will
experience acute episodes requiring urgent medical
treatment and hospitalisation. Hospital admissions for heart
failure are predicted to rise substantially over the next dec-
ade placing increasing pressure on the health care system
as health care costs associated with heart failure will also
dramatically rise. There is an urgent need to redesign health
systems of care for heart failure to improve evidence-based
practice and create seamless systems of care across the
health care continuum embracing primary care, hospital
and community care. This literature review will systematic-
ally review articles that focus on systems of care for heart
failure aimed at reducing hospital readmission and mortal-
ity rates. A system of care is defined as one or several inter-
ventions implemented for service delivery in health care.
Methods
Types of studies
Studies included in the review implemented an interven-
tion or interventions involving health service delivery
aimed at reducing hospital readmissions and mortality for
patients diagnosed with heart failure. Patients diagnosed
with heart failure with reduced (HFrEF) and/or preserved
ejection fraction (HFpEF) were included. All of the studies
included in the review had received ethics approval.
Search methods
The search strategy was based on the PRISMA statement
[8]. The following databases were searched for studies of
systems of care for heart failure:
1. The Cochrane Central Register of Controlled Trials
(CENTRAL, issue 7 of 12, searched 4/8/2015, results: 9)
2. MEDLINE (EBSCO host, 2008 to August week 1
2015, searched 4/8/2015, results: 145)
3. EMBASE (EMBASE platform, 2008 to 2015 week
31, searched 4/8/2015, results: 107)
4. CINAHL (EBSCO host, 2008 to August week 1
2015, searched 4/8/2015, results: 21)
The Cochrane Highly Sensitive Search Strategy was
used for MEDLINE and an adaptation of it for EMBASE
and CINHL [9]. See Appendix 1 for details of the search
strategies. We restricted the search to studies reported
in English and from 1st January 2008 to 4th August 2015.
There was no restriction on study design. We included
randomised controlled trials, non-randomised trails and
observational studies. All citations were imported into
EndNote XVIITM electronic database.
The following clinical trials registries were also searched:
WHO International Clinical Trial Registry Platform
(ICTRP) (www.who.int/trialsearch) and clinical trials
(www.clinicaltrial.gov ) (searched 5th August 2015). Full
reference lists of key eligible papers and review articles
were searched to identify potential papers. We also
searched the grey literature to identify unpublished theses,
policy documents and abstracts. Reference lists of heart
failure guidelines (national and international) and other
systematic reviews and meta-analyses were also searched.
Selection of studies
All titles and abstracts were assessed for eligibility by
three authors working independently. If the title and
abstract contained sufficient information to determine
exclusion, it was rejected. Where the type of interven-
tion or study population was not clear from the title or
abstract the full text of the paper was retrieved and eval-
uated to determine inclusion or exclusion. The reference
lists of eligible papers were reviewed to identify potential
papers. The principle reason for exclusion of papers and
abstracts was documented based on inclusion criteria.
Disagreements between the reviewers were resolved by
discussion and consensus between the three authors.
Assessment of quality of evidence for non-randomised con-
trolled trials
The Newcastle-Ottawa Scale (NOS) was used to assess
the quality of non-randomised studies [10] (Table 1).
This tool has been used previously in Cochrane Reviews
for assessment of risk of bias in non-randomised studies
with high inter-rater reliability and content validity [10].
The NOS comprises of eight items: representativeness of
cohort, selection of cohort, ascertainment of exposure,
outcome of interest was not present at baseline, compar-
ability of cohorts, assessment of outcome, length of
follow-up and adequacy of follow-up. When the paper
under review met the criterion in the NOS, it was
awarded a ‘*’. A paper was also awarded an additional ‘*’
if the analysis was adjusted for potential confounding
variables. The quality of each study was graded as low,
medium or high according to the number of stars (*).
Assessment of risk of bias for randomised controlled trials
The Cochrane Collaboration tool for risk assessment
[11] was used. Each randomised controlled trial was
assessed for selection bias, performance bias, attrition
bias, and detection bias (Table 2). The risk of bias was
assessed as low, high or unclear. Study quality was not a
reason for exclusion of a study.
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Data synthesis
Due to the diversity associated with the design and
outcome measures in observational and cohort studies,
meta-analysis for pooled estimates was not conducted so
the data was synthesised qualitatively and consisted of a
narrative synthesis of the evidence.
Results
A total of 520 studies were identified from the literature
search. After removing the duplicate articles we
reviewed the titles and abstracts of 487 articles. Of these
abstracts, 212 full-text articles were identified for
retrieval and possible inclusion in the literature review.
From the full-text articles we excluded 183 studies. We
included 29 studies in the integrated literature review.
The PRISMA flow diagram in Fig. 1 outlines the selec-
tion process of studies included in the literature review.
The studies were classified into four main categories,
based primarily on the environment of delivery, relating
to systems of care for heart failure: workforce, primary
care, in-hospital and transitional/community systems of
care. Workforce was included as a category as often the
intervention spanned across multiple environments such
as primary care, in-hospital and community. Appendix 2
provides a summary of the included studies. Systematic
reviews, meta-analyses and policy documents have been
excluded from Appendix 2.
Table 1 Summary of Quality Assessment (Newcastle-Ottawa Scale): Non randomised studies
Study Selection Comparability
of cohortsa
Outcome Evidence
qualityb
Exposed cohort
representative
Non exposed
cohort selection
Exposure
ascertainment
Outcome not
present at start
Assessment Follow-up
length
Follow up
adequacy
Workforce
Zuily, 2010 [15] * * * * ** * * * High
Boom, 2012 [13] * * * * ** * * * High
NICOR, 2012 [12] * * * * ** * * * High
Comin-Colet, 2014 [16] * * * * ** * – – High
Primary care
Lee, 2010 [18] * * * * ** * * * High
Rosstad, 2013 [17] * * * * – – – – Low
In-hospital studies
Williams, 2010 [21] * * * * – * * * Low
Tuso, 2014 [22] * * * * – * * * Low
In-hospital clinical audits/registries/quality improvement initiatives
Boutwell, 2011 [33] * * * * – NA NA NA Low
Heidenreich 2012 [26] * * * * ** * * * High
Hansen, 2013 [32] * * * * * * * * Moderate
H2H National Quality
Improvement Initiative,
2015 (H2H program) [34]
* * * * – NA NA NA Low
Transitional care
Driscoll, 2011 [45] * * * * ** * * * High
Outpatient clinics
Fonarow, 2011 [51] * * * * ** * * * High
Hernandez, 2010 [49] * * * * ** * * * High
Fenner, 2014 [50] * * * * – - * * Low
Telemonitoring programs
Piette, 2008 [60] * * * * – - * * Low
Baker, 2013 [61] * * * * ** * * * High
NA not applicable as outcome data has not been reported at the time of the literature search
aAlso includes controlling for potential confounders
bEvidence quality
Low: downgrading from moderate to low based on design or lack of information in report
Moderate: study met selection criteria (4 stars), comparability (1 star and upgraded a level for 2 stars), and outcome assessment
High: upgrading from moderate to high based on comparability of 2 stars
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Specialist workforce
When redesigning systems of care, an experienced work-
force is critical to its success. Three studies examined
the impact of workforce on patient outcomes. All of
these studies were rated as a high quality of evidence
(Table 2). Specialist heart failure teams within the com-
munity and in-hospital were associated with improved
patient outcomes. A UK national heart failure audit,
conducted between April 2010 to March 2011, found in-
patient mortality rates were better in patients admitted
under Cardiology (8 %) compared to General Medicine
(14 %) and other wards (17 %) [12]. In another study,
these benefits were also extended to lower 30-day and
12 month mortality rates [13]. Boom and colleagues [13]
recruited 7634 patients newly hospitalised with heart
failure. Patients who were admitted under a generalist
physician and had a cardiologist involved in their care
were more likely to undergo cardiac investigations dur-
ing their inpatient stay. Patients treated by a generalist
physician only were also at increased risk of 30-day mor-
tality (odds ratio [OR] 1.50, 95 % confidence interval
[CI] 1.18–1.91) compared to patients that were admitted
under a generalist physician and had a cardiologist
involved in their care [13].
Table 2 Risk of bias: Randomised controlled trials
Author, year Random sequence
generation
Allocation
concealment
Blinding of participants
and personnel
Blinding of outcome
assessment
Incomplete
outcome data
Selective
reporting
Other
bias
Overall risk
of bias
Transitional care7
Jaarsma, 2008 [44] Low Unclear High Low Low Low None Low
Nurse-led outpatient clinic
Driscoll, 2014 [45] Low Unclear High Unclear Low Low None Low
Telemonitoring programs
Schwarz, 2008 [59] Unclear Low High Unclear Unclear Low None Unclear
Woodend, 2008 [57] Unclear Low High Unclear Low Low None Low
Chaudhry, 2010 [55] Low Unclear High Low Unclear Low None Low
Koehler, 2011 [52] Low Unclear High Low Low Low None Low
Angermann, 2012 [39] Low Low High Low Low Low None Low
Dendale, 2012 [54] Low Low High Low Low Low None Low
Pekmezaris, 2012 [56] Low Unclear High Unclear Low Low None Low
Krum, 2013 [53] Low Low Low Low Low Low None Low
Black, 2014 [58] Low Low Low Unclear Unclear Unclear None Unclear
Fig. 1 Study flow diagram
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Improved outcomes were also seen in outpatient
settings with lower mortality rates for patients followed
up with cardiology clinics (18 %) compared to non-
cardiology clinics (31 %) [12]. There was also a similar
trend with patients followed up with heart failure
specialist nursing services (22 % mortality rate) com-
pared to follow up with a non-heart failure specialist
nurse (27 %) [12]. A dedicated in-hospital heart failure
unit also showed further reduction in heart failure
readmissions and all-cause event-free survival [14, 15].
Comin-Colet and colleagues [16] implemented a
health service-wide heart failure program encompassing
an inpatient service, community service and a heart fail-
ure unit including a multidisciplinary specialist heart
failure team. They examined hospital readmissions and
mortality rates of 2083 patients, admitted with acute
decompensated heart failure, to the hospital with a heart
failure service compared to the outcomes associated
with 54 659 patients admitted, with acute decompen-
sated heart failure, to hospitals with no heart failure
service within the surrounding region. They found that
patients admitted to the hospital with the heart failure
service had a lower risk of death (hazard ratio [HR] 0.92,
95 % CI 0.86–0.97), 29 % less likely to experience a
readmission for any cause (HR 0.71, 95 % CI 0.66–0.76),
and 14 % lower risk of heart failure readmissions (HR
0.86, 95 % CI 0.80–0.94) [16].
Primary care
Most of the literature examining systems of care for
heart failure in primary care focused on a collaborative
model of care and adherence to clinical guidelines. Of
the two studies included, one was rated as a low [17]
quality of evidence and the other as high [18] (Table 1).
Lee et al. [18] examined readmission rates of 10 599
heart failure patients discharged from emergency depart-
ment (ED) who were managed in a collaborative care
model comprising of a cardiologist and general
practitioner compared to general practitioner only or no
follow-up. Collaborative care (cardiologist and general
practitioner) reduced mortality compared with general
practitioner only (HR 0.79; 95 % CI 0.63 to 1.00) [18].
Care pathways have also been trialed in primary care.
Roostad [17] found that a disease-based care pathway was
ineffective and unsustainable in primary care. This was
mainly due to multiple co-morbidities that can be
associated with heart failure and the need for multiple
care pathways for each co-morbidity which may be
contradictory to other care pathways. This study was rated
as low quality of evidence as there was no follow up.
In-hospital care
Many studies implemented interventions to improve the
translation of clinical practice guidelines into standard
patient care with the aim of reducing 30 day readmis-
sions. Hansen [19] undertook a systematic review of
interventions implemented pre and post discharge to
reduce 30-day readmissions. Pre-discharge interventions
included: patient education, medication reconciliation,
discharge planning, and scheduling of a follow-up ap-
pointment before discharge. Post-discharge interventions
comprised of: follow-up telephone calls, patient acti-
vated hotlines, timely communication with ambulatory
providers, timely ambulatory provider follow-up, and
post-discharge home visits. Bridging interventions
included transition coaches, physician continuity across
the inpatient and outpatient setting, and patient
centered discharge instruction. Hansen [18] found that
no single intervention alone was associated with reduced
risk for 30-day readmissions rather bundles of interven-
tions were more effective. Care pathways were also
associated with improved patient outcomes.
In the acute hospital setting, a meta-analysis of care path-
ways reported reductions in readmission (RR 0.81, 95 % CI
0.66–0.99) and in-hospital death rates (RR 0.45, 95 % CI
0.21–0.94) compared with usual care in patients
hospitalized with acute heart failure [20]. However, the
meta-analysis combined results from three randomised
controlled trials, one interrupted- time series and three
controlled trials so differences in patient characteristics
may have affected the outcomes [20]. A limitation of care
pathways is that one standardised care pathway will not be
suitable for all hospitals so effectiveness varies greatly and
the results of the meta-analysis should be interpreted with
caution. Care pathways were also not found to be effective
or sustainable in primary care [17].
In addition to a systematic review and meta-analysis, two
studies implemented a system of care during the inpatient
phase. Williams [21] implemented a quasi‑experimental
study to determine the effectiveness of an inpatient educa-
tion program and discharge planning on reducing hospital
readmission. All patients were followed up for 18 weeks
post-discharge. They found no difference between groups
for 30 day hospital readmissions. There was a significantly
shorter length of hospital stay for patients in the education
program compared to no education (10.68 days versus
9.58 days, p = 0.05) [21]. The study had a low quality of evi-
dence due to lack of controlling for confounding variables
(Table 1).
One study implemented a ‘heart failure bundle’ [22].
This study was rated as a low quality of evidence mainly
due to a lack of controlling for confounding variables
during data analysis (Table 2). The bundle included: in-
patient heart failure education, a home visit within 48 h
of discharge, and a follow-up appointment and follow-
up phone call from a heart failure care manager both
within seven days of discharge. Readmissions rates were
reduced from 19 to 15 % over 30-days (p = 0.03) [22].
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In-hospital quality of care performance initiatives
Several studies discussed the implementation of large
quality improvement programs and clinical inpatient
registries to improve hospital management of heart
failure patients. Considerable variation in the manage-
ment of heart failure between hospitals exists [12, 21,
23]. Several studies showed an improvement in survival
and reduction in readmission rates as patients with heart
failure were cared for in hospitals that complied with
clinical practice guidelines compared with hospitals with
low compliance rates [23–26].
Clinical audits/registries
There are several national registries throughout the
world: HEARTS in Saudi Arabia, CHART-2 in Japan,
GULF CARE in Middle East, and ASIAN-HEART
FAILURE in Asia [27]. Results from these registries are
yet to be published. The implementation of many large
clinical registries and clinical audits occurred prior to
the time period of this literature search such as
OPTIMISE [24], and ADHERE [23] and EuroHeart
failure survey I [28] and II [2]. However, one large clin-
ical audit was the UK national audit [12]. This study was
assessed as a high quality of evidence rating (Table 2).
UK national heart failure audit In England and Wales,
over the past four years, an annual national audit of
patients admitted to hospital with acute decompensated
heart failure has been undertaken. The latest national
audit conducted between April 2010 and March 2011
collected data on 36 items (based on national guidelines)
from 133 National Health Service Trusts and Welsh
Health Boards on 36 504 patients representing 54 % of
all hospital admissions for acute decompensated heart
failure [12]. The audit found a large degree of heterogen-
eity in the management of heart failure across hospitals
particularly the proportions of patients undergoing key
diagnostic tests, receiving cardiovascular medications on
discharge and being referred to cardiology follow-up
services [12]. In-hospital mortality was lower for those
patients admitted under Cardiology (8 %) compared to
those patients admitted under General Medicine (14 %)
and other Units (17 %). This trend also extended to
post-discharge with an 18 % mortality rate with Cardi-
ology follow-up compared to 31 % with non-cardiology
follow up [12]. A similar trend was seen with patients
followed by a specialist heart failure nurse at 22 %
mortality compared to 27 % with no follow up with a
heart failure specialist nurse. Unfortunately, hospital
readmissions were not collected in the audit [12].
Quality improvement initiatives
Several nationwide quality improvement initiatives have
also been implemented with the aim of reducing 30-day
hospital readmissions. These include: Get with the Guide-
lines (GWTG)-HEART FAILURE, Better Outcomes for
Older adults through safe transitions (BOOST) project,
State Action on Avoidable Rehospitalisations (STAAR)
program, and Hospital-to-Home program (H2H).
GWTG-heart failure The GWTG program was imple-
mented by American Heart Association to address the
gap in implementation of evidenced-based clinical prac-
tice guidelines with the aim of improving patient out-
comes post discharge. Several disease-specific GWTG
programs have been implemented: GWTG-Atrial Fibril-
lation, GWTG-Resuscitation, and GWTG-stroke. Regis-
tered hospitals receive access to GWTG toolkit specific
for heart failure. The toolkit comprises of: initiation of
evidence-based medications, implantation of appropriate
device therapies, discharge education about heart failure,
evaluation of left ventricular function, and post dis-
charge follow-up appointment [29]. Data is then entered
into a web based system and each participating hospital
receives site level patient data to identify those at risk of
readmission. The program also provides professional
education, patient education resources, and clinical
support tools. GWTG currently has data from over 5
million patients and over 2093 US hospitals that partici-
pated at least once in GWTG (http://www.heart.org/
HEARTORG/HealthcareResearch/GetWithTheGuideline
sHEART FAILUREStroke/GetWithTheGuidelinesHeartF
ailureHomePage/Get-With-The-Guidelines-Heart-Failur
e-Home-Page_UCM_306087_SubHomePage.jsp) [29]. Re-
sults have shown an improvement in adherence to
performance measures and systems of care but subse-
quent impact on patient outcomes has been disappointing
[26, 30, 31]. Readmissions at 30-days was 24.5 % and
mortality at 30 days was 11 % [26]. Readmission rates [26]
and mortality [31] were significantly lower in hospitals
participating in GWTG- heart failure. This study [26] had
a high quality of evidence (Table 1).
BOOST project (Better Outcomes for Older adults
through safe transitions) [32]. This was a quality im-
provement project to reduce hospital readmissions and
length of stay for patients hospitalised with heart failure.
Thirty hospitals enrolled in the project but only eleven
submitted their data. In 2014, 180 hospitals were
involved in the project [32]. The BOOST intervention
consisted of a toolkit which contained: an implementa-
tion guide, project management tools, such as the Teach
Back Training Curriculum, and PICO guidelines to
evaluate the intervention. Sites were also provided with
face‐to‐face training and 12 months of expert mentoring
and coaching, and assistance to build a culture that sup-
ports organisational change to reduce hospital readmis-
sions, also linking with other participating sites and data
Driscoll et al. BMC Cardiovascular Disorders  (2016) 16:195 Page 6 of 20
management. Each site also received project benchmark
data and site level patient data. The average rate of 30-
day rehospitalisation was 15 % pre-implementation and
13 % 12 months post-implementation [32]. There was
no difference in length of stay. Unfortunately, not all of
the hospitals implemented all of the quality tools, with
the majority implementing two of the five BOOST tools.
This study was rated as a moderate quality of evidence
due to not adjusting for confounding variables (Table 1).
STAAR program
State Action on Avoidable Rehospitalisations initiative
[33]. This program involved a state- based approach to
reducing 30-day hospital readmissions. It involved 148
hospitals partnering with community based organisa-
tions with the aim of improving communication and the
transition between health care providers. The interven-
tion also comprised of multi-stakeholder, state-level
steering committees. These committees coordinated
programs throughout the State aligning partners and
troubleshooting barriers to implementation [33]. The
collaborative cross-continuum teams included health
professionals from acute care, community health
programs, Aged Care facilities, ambulatory care, social
services, patient and family caregivers. Each hospital was
expected to perform a comprehensive assessment of
patients’ needs post-discharge, provide patient and carer
education, provide clear discharge information to the
patient, carer and community provider and ensure early
post-discharge follow-up for medical and non-medical
services. At the time of writing the systematic review,
results from STAAR were not published. The study was
rated as a low quality of evidence due to a lack of infor-
mation about their outcome data.
Hospital to home (H2H) The Hospital to Home (H2H)
[34] Initiative provided a toolkit to clinicians to assist
them in implementing evidence-based care from clinical
guidelines, within their organisation. The toolkit
contained evidence-based clinical information, webinars
and recommended strategies and tools to improve
evidence-based practice. The goal of the toolkit was for
all patients to have a follow-up appointment/cardiac
rehab referral within seven days of discharge, improved
medication management, and information about early
warning signs and a care plan to address them [34]. At
the time of the conducting this literature search the only
published article was an evaluation done by Bradley [35].
Bradley [35], undertook a survey of 537 hospitals en-
rolled in the H2H program, to determine their resources
for reducing heart failure readmissions. All of the hospitals
reported monitoring their performance data in particular
30-day readmissions rates. Two thirds of the hospitals had
a designated person or group to review unplanned
readmissions that occurred within 30 days of discharge.
On average, hospitals implemented less than half of the 10
recommended H2H practices. Less than 3 % of the hospi-
tals, routinely used all 10 [35]. The H2H programs was
rated as low quality of evidence due to a lack of published
information about their outcome data (Table 1).
Transitional/community based care
Most transitional care literature focussed on post-discharge
heart failure programs and implementing single site specific
interventions. Numerous meta-analyses have shown that
heart failure programs reduce hospital readmissions and
mortality [36–38]. Meta-analyses of heart failure programs
found a large degree of heterogeneity between studies and
no single intervention was able to be isolated to determine
their effectiveness. Rather the effectiveness of many
discharge programs was due to a bundle of interventions
[16, 22, 40, 41]. A quality improvement tool was developed
from a national survey of heart failure programs and data
from 573 patients enrolled in those programs [40]. The
quality improvement tool showed that the more interven-
tions implemented within a program the greater the
improvement in patient outcomes. Patients participating in
complex programs were 20 % less likely to experience a
hospital readmission and/or mortality (HR 0.80, 95 % CI
0.70–0.92) compared to less complex programs [40]. This
study was rated with a high quality of evidence (Table 1).
The use of specialist heart failure nurses within the heart
failure programs also improved patient outcomes [12].
Several meta-analyses of heart failure programs have
shown an improvement in patient outcomes in programs
where nurses are experienced in heart failure and have
qualifications in a cardiac speciality and/or critical care. A
randomised control trial of a heart failure program involv-
ing generic nurses with no cardiac experience found a
13 % reduction in hospital readmissions [42] compared to
meta-analyses involving heart failure nurses showing a
30 % reduction in hospital readmissions [36, 43].
Jaarsma and colleagues [44] implemented a randomised
controlled trial to determine the effect of low, moderate
or high intensity, post-discharge follow up with a heart
failure nurse. Low intensity follow-up or usual care com-
prised of an outpatient appointment with a Cardiologist
within two months post-discharge and then every six
monthly. Moderate follow-up consisted of usual care and
nine outpatient appointments with a heart failure nurse.
High intensity follow-up also consisted of usual care and
weekly telephone calls and a home visit within the first
month post-discharge, followed by additional telephone
calls with the heart failure nurse, two home visits and two
multidisciplinary appointments. They found that neither
moderate nor intensive follow up by a heart failure nurse
reduced the combined end points of heart failure death
and hospitalization compared with usual care. At
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18 months, 411 patients (40 %) were readmitted because
of heart failure or died from any cause [44]. There was no
significant difference in heart failure readmission or mor-
tality between the three groups: 42 % in the control group,
and 41 % and 38 % in the basic and intensive support
groups, respectively (P = .73 and P = .52, respectively) [44].
Nurse-led medication titration
Nurse-led medication titration in heart failure patients has
been shown to improve patient outcomes whether in a
clinic or in the community. Driscoll and colleagues [45]
examined nurse-led titration of beta-adrenergic blockers by
heart failure nurses in the community during a home visit.
They recruited 484 patients diagnosed with HFrEF partici-
pating in 33 heart failure programs. The study found all-
cause hospitalisations and mortality was lower in patients
participating in programs allowing nurse-led titration of
beta-adrenergic blocking agents (HR 0.58, 95 % CI 0.42–
0.81) [45]. The study was assessed as a high quality of
evidence (Table 1). Driscoll et al. [46] also implemented a
randomised controlled trial of a nurse-led titration clinic
for patients diagnosed with HFrEF. Patients were rando-
mised to titration of beta-adrenergic blocking agents by a
nurse in an outpatient clinic or follow up by their general
practitioner for titration of these medications [46]. The
nurse-led medication titration clinic resulted in a 50 % re-
duction in time to optimal dose of beta-adrenergic blocking
agents compared with optimisation of beta-adrenergic
blocking agents by general practitioners (90 ± 14 days vs
166 ± 8 days, p < 0.0005) [46]. Risk of bias was assessed as
low (Table 2). A meta-analysis of nurse-led titration, regard-
less of the setting, found that patients participating in
nurse-led titration of beta-adrenergic blocking agents and
angiotensin converting enzyme inhibitors were 21 % less
likely to be readmitted for any cause (HR 0.79, 95 % CI
0.36–0.72) and 34 % were less likely to die [47].
Outpatient clinics
Literature involving outpatient clinics was mainly concerned
with a lack of follow-up post-discharge and the benefits of
follow-up in a heart failure clinic compared to generalist
clinics. A recent analysis of Medicare claims data in the
USA, found that of the patients hospitalised for heart fail-
ure, 52 % of patients did not have an outpatient visit [48].
Heart failure clinical guidelines recommend early
follow-up within 7–10 days post-discharge [49–51].
GWTG-HEART FAILURE found the median percentage
of patients who had early follow-up after discharge from
the index hospitalization was 38.3 % (interquartile range,
32.4 %–44.5 %) [49]. There was a large degree of variation
between hospitals for early outpatient follow-up after dis-
charge. Patients who had higher early follow-up appoint-
ments had a lower risk of 30-day readmission [49]. This
study was rated as a high quality of evidence (Table 2).
Another study implemented follow-up at a heart failure
clinic, within three days post-discharge [50]. There was a
reduction in heart failure readmission rate from 18 % to
13 % [50]. The heart failure service was then extended to
include telemedicine, using basic videoconferencing for
patients living in rural and remote areas. Heart failure
readmissions for this group of patients was reduced from
18 % to 10 % over a six month period [50]. There was a
low quality of evidence for this study mainly due to no
adjustment for potential confounding variables (Table 1).
The Registry to Improve the Use of Evidence-Based
Heart Failure Therapies in the Outpatient Setting
(IMPROVE-HF) is a national registry and performance
improvement program of 15381 patients with chronic
HFrEF from 167 outpatient cardiology practices [51].
The IMPROVE-HF study found an increase in adher-
ence in performance measures was significantly associ-
ated with improved survival [51]. This study was rated
as a high quality of evidence (Table 1).
Telemonitoring/telehealth
Telemonitoring is another transitional care intervention,
particularly for those patients who do not have access to a
Cardiologist or heart failure nurse. Telemonitoring in-
volves automated transmission of patient data to a central
service and includes measures such as patient-measured
weight, blood pressure, heart rate and heart rhythm. A
study by Cleland and colleagues [6] found mortality rates
at 12 months were lower in patients participating in
telemonitoring (29 %) or regular telephone support from a
nurse (27 %) compared with usual care (45 %). In contrast,
Koehler and colleagues [52] found no differences in mor-
tality between the telemonitoring and usual care groups
over 12–28 months. Nine randomised controlled trials
investigated the effect of telemonitoring on hospital
readmission and/or mortality. The risk of bias associated
with these studies was low in seven studies [52, 39, 53–57]
and unclear in two [58, 59] (Table 2). There were also two
non-randomised studies that implemented a telemonitor-
ing system, one study was rated as low [61] quality due to
the lack of controlling for potential confounders and the
other study was rated as high [61].
The Chronic Heart Failure Assessment by Telephone
(CHAT) study investigated the utility of a telephone-based
automated telemedicine system for patients diagnosed with
HFrEF and living in rural and remote Australia [53]. The
participants were required to dial into the telemedicine
system monthly. The patients were required to answer
questions about their heart failure clinical status, medical
management of their condition and social questions rele-
vant to their heart failure status. Alerts were set up within
the Telewatch system alerting the CHAT nurse via the
Patient Watch Screen to follow up patients that reported
pre specified signs or symptoms warranting intervention. In
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patients randomised to the telemedicine system there were
fewer patients hospitalised for any cause (74 versus 114,
adjusted HR 0.67 [95 % CI 0.50–0.89], p = 0.006). Also less
patients died and/or were hospitalised (89 versus 124,
adjusted HR 0.70 [95 % CI 0.53–0.92], p = 0.011), compared
to the usual care group [53]. The risk of bias associated
with this study was low (Table 2).
The ‘telemonitoring in the management of heart failure’
(TEMA-HF) study did find a significant difference in mor-
tality but not in readmission rates [54]. They randomised
160 patients hospitalised with heart failure to usual care or
an intervention group. Patients randomised to usual care
received a cardiology outpatient clinic within two weeks of
discharge. Patients in the intervention group were provided
with a telemonitoring system to use at home with in-built
alerts when the patient’s vital signs fell below a predeter-
mined level prompting follow up by a heart failure nurse,
and a consultation service between the general practitioner
and cardiologist concerning clinical management of the
patient. At six months, all-cause mortality was significantly
lower in the telemonitoring group compared to usual care
(5 % versus 17.5 %, respectively, p = 0.01) but there was no
significant difference in heart failure hospitalisations be-
tween the telemonitoring and usual care groups (0.24 ver-
sus 0.42 hospitalisations/patient, respectively, p = 0.06) [54].
The Health Buddy Program integrated a telehealth sys-
tem with care management [61]. The program had 15 %
lower risk-adjusted all-cause mortality (HR 0.85, 95 % CI
0.74–0.98; P = .03) and had reductions in the number of
quarterly inpatient admissions from baseline to the study
period that were 18 % greater than those of matched
controls during this same time period [61]. There was a
high quality of evidence associated with this study
(Table 1). The BEAT-HF study is currently underway
[58]. Patients will be randomised into an intensive pa-
tient education group using the ‘teach-back’ method and
receive instruction in using the telemonitoring equip-
ment. Following hospital discharge, they will receive a
series of nine scheduled health coaching telephone calls
over 6 months from nurses located in a centralized call
center. The nurses will call patients and patients’ physi-
cians in response to alerts generated by the telemonitor-
ing system, based on predetermined parameters [58]. As
results are currently not available the risk of bias associ-
ated with this study was unclear (Table 2).
A systematic review and meta-analysis of telemonitor-
ing programs [63, 62] found a lower all-cause readmis-
sion rate and mortality for patients participating in a
telemonitoring program. However, since that time, two
large telemonitoring RCTs have found that telemonitor-
ing had no effect on reducing hospital readmissions or
mortality [52, 56]. Chaudhry [55] implemented an RCT
of telemonitoring in 1653 patients recently admitted to
hospital for acute decompensated heart failure. The
telemonitoring program consisted of a telephone-based
interactive voice response system that collected daily
information about symptoms and weight that were
reviewed by the patients’ clinicians. Patients were asked
to dial into the system daily. During each call patients
were asked several questions about their general health
and heart failure symptoms. Chaudhry [55] found no
difference in hospital readmission and mortality between
the telemonitoring group and usual care. The study was
reported as a low risk of bias (Table 2).
Koehler and colleagues [52] also implemented a telemo-
nitoring program involving the randomisation of 710
chronic heart failure patients to a telemonitoring program
or usual care. Similar to Chaudhry et al. [55], this study
was also rated as a low risk of bias (Table 2). The telemo-
nitoring program consisted of: portable devices for ECG,
blood pressure, and body weight measurements. Patients
were required to undertake daily self-assessments and the
data was transferred to the telemonitoring data centre.
They found no significant difference in all-cause mortality
or heart failure hospitalisation [52]. Pekmezaris and col-
leagues [56] also implemented a similar telemonitoring
system and randomised 168 patients, post hospitalisation
for heart failure, into usual care or telemonitoring groups.
They found no significant differences in 30 and 90-day re-
admission rates between usual care and telemonitoring
groups [56]. Schwarz and colleagues [59] also randomised
102 patients and their carers to usual care or telemonitor-
ing and found no significant differences between the
groups for hospital readmissions at 90 days post-discharge
(13 versus 12 respectively, p = 0.6) [60]. The risk of
bias was assessed as unclear as only an abstract was
available. Woodend and colleagues [57] also found a
non-significant difference between their telemonitor-
ing and usual care groups for hospital readmission at
90 days (5.48 % difference between groups, p > 0.05)
and at one year post-discharge (−4.17 % difference,
p > 0.05) [57].
Angermann and colleagues [39] also found no significant
differences in their primary endpoint of hospital readmis-
sion rates, between usual care and telemonitoring groups.
Angermann et al. [39] randomised 715 patients hospitalised
with acute decompensated heart failure into one of two
groups: usual care consisted of discharge planning and fol-
low up with a cardiologist within 7–10 days post-discharge
(363 patients) or to HeartNetCare-HF (HNC) comprising
of inpatient visits with a heart failure nurse, structured
telephone-based monitoring system including blood pres-
sure, pulse and symptoms, uptitration of key medication
and access to specialist care as required (352 patients) [39].
All patients were followed up for 180 days. There was no
significant difference in the composite endpoint of all-cause
hospitalisation or mortality (HR, 1.02; 95 % CI, 0.81, 1.30;
P = 0.89) [39]. There was a slightly higher rate of
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readmissions in the HNC group compared to usual care
(119 versus 112 respectively) but this was not statistically
significant between the groups [39].
Discussion
There was a paucity of studies that focussed on systems
of care for heart failure with a primary outcome of
readmission rates. Several studies recommended the
implementation of a heart failure service or unit to
manage heart failure patients regardless of the setting.
Unfortunately, the translation of this evidence into clin-
ical practice is poor, contributing to higher readmission
and mortality rates [12, 64–66].
In primary care, several studies implemented a collab-
orative model of care for the management of patients
diagnosed with heart failure. General practitioners are the
cornerstone of managing heart failure patients in the com-
munity. However, there were only a few studies that were
based in primary care. Difficulty in diagnosing heart
failure due to the non-specific signs and symptoms can be
challenging for general practitioners and may partly ex-
plain the under diagnosis of heart failure. Vilesca and col-
leagues [67] found that a general practitioner in primary
care had a total of 10 guidelines that addressed diagnostics
in heart failure. However, the criteria for diagnosis varied
greatly [67]. This may contribute to a 12 % misdiagnosis
rate for heart failure when general practitioners are
responsible for the initial diagnosis [68]. The paucity of
randomised controlled trials in primary care, focussing on
improving systems of care for heart failure patients, high-
lights the need for more research in this area.
The main driver in improving inpatient systems of care
for heart failure has been the 30-day readmission quality
performance indicator in the USA. As a consequence,
several large national quality improvement programs and
clinical registries have been implemented throughout the
USA. These programs have been effective in improving
the translation of clinical guidelines into practice. How-
ever, reducing 30-day readmissions remains elusive. This
raises the question: are 30 day readmissions the appropri-
ate benchmark to use for reimbursement and as an indica-
tor of hospital quality? Focussing on 30 days readmissions
may under estimate the burden of heart failure and per-
haps aiming our interventions at reducing heart failure
readmissions over a longer period of time would be more
effective. Over the last few years, hospitalisations, length
of stay and in-hospital mortality for heart failure, have all
improved, however, 30 day readmissions have not. It is un-
clear if this is due to inherent problems with the clinical
indicator or inadequate progress with improving discharge
planning and transitional care. Due to the chronicity asso-
ciated with heart failure, effective systems of care need to
encompass an outcome measure of readmission rates
greater than 30 days. In order to improve hospital
readmissions for heart failure a national co-ordinated ap-
proach is vital, with national benchmarking and collabor-
ation between health professionals, particularly focusing
on improving systems of care for managing inpatient heart
failure patients.
A smooth, safe and efficient transition from hospital to
home is essential to avoid hospital readmissions. The chal-
lenge is ensuring a seamless transition from hospital to
outpatient care to long-term community care whilst not
compromising on quality or adherence to evidence-based
practice and maintaining linkage with a heart failure
specialist team. Transitional care incorporates heart failure
programs in the community and outpatient clinics. There
was a high level of evidence supporting the imple-
mentation of nurse-led medication titration clinics. A
meta-analysis of nurse-led clinics for the titration of key
therapeutic medications reduced hospital readmissions
and mortality [47]. An outpatient clinic appointment
within 7–10 days post-discharge was also associated
with a lower risk of hospital readmission [49]. In par-
ticular, an early follow-up with a cardiologist and their
general practitioner improved patient survival [18].
Several clinical registries have also been implemented
to monitor the quality of outpatient care. They all
report an improvement in adherence to guideline
recommended therapy [49, 51].
Several transitional programs also included telemon-
tioring or telehealth. However, due to conflicting results
between large randomised controlled trials, more
research is needed in this area. A meta-analysis incorp-
orating recent conflicting randomised controlled trials is
urgently warranted.
Limitations
The main limitation of this integrated review was the
quality of studies. The majority of the studies were
descriptive and conducted at a single centre with few
multicentre randomised controlled trials. A meta-
analysis of these studies was not conducted due to the
heterogeneity of the interventions, variability in primary
endpoints, length of follow-up and study design. In
terms of the quality of the evidence, eight of the 17 non-
randomised studies were rated as low due to a lack of
controlling for potential confounding variables so their
results should be interpreted with caution. There were
also two studies that had, to date, not published their
outcome data so the quality of their evidence was also
rated as low. However, it was important to include these
studies in the review due to the innovative and poten-
tially effective programs being implemented. Two of the
six randomised controlled trials had their risk of bias
assessed as unclear. In both of these studies only the ab-
stract was available so full information to assess risk of
bias was unable to be accessed.
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Conclusion
A suite of interventions, co-ordinated by a heart failure
specialist workforce, are needed across the continuum of
care to improve the translation of evidence into practice
in patients diagnosed with heart failure. In primary care,
collaborations between the general practitioner and
cardiologist have been effective at improving evidence-
based practice. During hospitalisation, quality improve-
ment programs have improved the quality of inpatient
care. In the transitional care phase, heart failure pro-
grams, nurse-led clinics, and early outpatient follow-up,
reduced hospital readmissions. Importantly, there needs
to be a seamless transition of care across the continuum
with improved communication and co-ordination be-
tween services.
Clinical guidelines recommend evidence-based prac-
tice that improves patient outcomes. However, the trans-
lation of evidence into practice is lacking. More work
needs to be done to bridge the evidence-practice gap to
improve outcomes for heart failure patients and to re-
duce hospital readmissions.
Appendix 1
1. Medline and Cinahl and Cochrane search strategy
#1 “heart failure” OR “cardiac failure”
#2 prevent* OR reduc* OR improv* OR avoid* OR
readmi* OR recommend*
#3 (#1 AND #2)
#4 "care model" OR “model of care” OR "system* of
care" OR "care management" OR "patient-cent* care"
#5 (#3 AND #4)
#6 (emergency OR acute OR primary OR community
OR after OR ambulatory OR transition* OR aged) N3
care
#7 “acute hospital” OR “general practice”
#8 (#6 OR #7)
#9 (#5 AND #8)
2. EMBASE search strategy
3. Grey literature search strategy
Google Advanced :-
("heart failure" OR "cardiac failure") AND (policy OR
guideline) AND (prevent OR prevention OR reduce OR
reduction OR readmission OR improve OR improve-
ment) AND ("care model" OR "model of care" OR "man-
agement systems" OR "system of care" OR "patient
centered care" OR patient centred care”)
 PDF and Microsoft Word document file types only
 .gov and .org domains
Table 3 Search strategies
Database searched Results 31st July
2015
MEDLINE, 1st January 2008 to 31st July 2015 145
CINHAL , 1st January 2008 to 31st July 2015 21
EMBASE, 1st January 2008 to 31st July 2015 107
THE COCHRANE LIBRARY, Issue 7 of 12, July (2015).
1st January 2008 to 31st July 2015
9
Grey Literature 1st January 2008 to 31st July 2015 238
Total (including duplicates) 520
#1 'heart failure'
#2 'cardiac failure'
#3 #1 OR #2
#4 prevent OR prevention
#5 reduce OR reduction
#6 improve OR improvement
#7 avoid OR avoided OR avoidance
#8 readmit OR readmission OR readmissions
#9 recommend OR recommendations
#10 #4 - #9 OR
#11 #3 AND #10
#12 'care model'
#13 ‘model of care’
#14 'system of care'
#15 'systems of care'
#16 'care management'
#17 'patient centered care’
#18 ‘patient centred care’
#19 #12 - #18 OR
#20 #11 AND #19
#21 (emergency NEAR/3 care)
#22 (acute NEAR/3 care)
#23 (primary NEAR/3 care)
#24 (community NEAR/3 care)
#25 (after NEAR/3 care)
#26 (ambulatory NEAR/3 care)
#27 (transition NEAR/3 care)
#28 (transitional NEAR/3 care)
#29 (aged NEAR/3 care)
#30 ‘acute hospital’
#31 ‘general practice’
#32 #21 - #31 OR
#33 #20 AND #32
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Appendix 2
Included studies of systems of care for heart failure
Table 4 Included studies of systems of care for heart failure (excluding systematic reviews, meta-analyses and policy documents)
Authors, year Sample Study design Intervention Outcomes
Workforce
Zuily, 2010 [15] 3200 patients admitted to
hospital with ADHF from
1997 to 2007
Pre and post-test
design
A heart failure unit was
implemented in 2002.
All patients received an
outpatient appointment
with the unit within one
month post-discharge. The
visits included patient
education, assessment
with the Cardiologist and
up-titration of medications.
Patients were followed up
monthly with six weekly
education sessions.
heart failure related
readmissions were reduced
from 21.7 % in 2002 to
15.6 % in 2007 (p < 0.0001)
Boom, 2012 [13] 7634 patients hospitalized for
ADHF who were participating
in the EFFECT trial
Retrospective cohort
study
Patients were divided as
to whether they received
cardiologist, general
practitioner, or general
practitioner with cardiology
consultation
Patients treated by general
practitioners alone had
higher risk of 30-day
(OR 1.50, 95 % CI 1.18–1.91)
and 1–year mortality
(OR 1.29, 95 % CI 1.10–1.50)
NICOR, 2012 [12] 36 504 patients admitted to
hospital with heart failure
UK national audit
consisting of
retrospective review
of medical records
Not applicable In-patient mortality rates:
-Cardiology 8 %
-Gen Med 14 %
Outpatient clinics mortality
-Cardiology 18 %
-non Cardiology 31 %
Community follow-up
mortality
-Heart failure nurse 22 %
-non heart failure nurse 27 %
Comin-Colet,
2014 [16]
2083 patients admitted with
ADHF to the hospital with a
heart failure service compared
to 54 659 patients admitted to
hospitals with no heart failure
service
Retrospective cohort
study
Implemented a health
service wide heart failure
program encompassing an
inpatient service,
community service and a
heart failure unit including
a multidisciplinary specialist
heart failure team.
Patients admitted to the
hospital with the heart
failure service had a lower
risk of death (hazard ratio
0.92, 95 % confidence
interval, 0.86–0.97), 29 %
less likely to experience a
readmission for any cause
(95 % confidence interval,
0.66–0.76), and 14 % lower
risk of heart failure
readmissions (95 %
confidence interval,
0.80–0.94)
Primary care
Lee, 2010 [18] 10 599 patients who presented
with heart failure and were
discharged from an ED in
Ontario
Retrospective cohort
study
Patients were divided into
one of three groups:
collaborative follow-up with
a cardiologist and primary
care physician, primary care
physician only follow-up,
and no follow-up
Collaborative follow up
with a cardiologist and
primary care physician
reduced 30 day mortality
compared to primary care
physician only (HR 0.79;
95 % CI 0.63 to 1.00).
Rosstad, 2013 [17] 19 clinicians participated in
focus groups.
Qualitative study,
focus interviews
27 clinicians were identified
as clinical champions to
facilitate the implementation
of clinical pathways. Focus
groups were conducted to
discuss the implementation
of the care pathway.
A disease-orientated care
pathway was not sustainable
or appropriate to use in
primary care.
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Table 4 Included studies of systems of care for heart failure (excluding systematic reviews, meta-analyses and policy documents)
(Continued)
In-hospital studies
Williams,
2010 [21]
Patients admitted to hospital
with HFrEF. 50 patients were
allocated to the historical
group and 47 to the
transitional care group
Quasi-experimental
design. All patients
were followed up for
18 weeks.
In-hospital education and
follow-up arrangements
either an appointment at the
nurse-led clinic or home visits
by the community heart
failure nurse.
30 day readmissions were
lower in the transitional
care group at 8 % vs 14 %
in the historical group.
Tuso, 2014 [22] 2076 hospital readmissions
within 30 days post discharge
from a hospitalisation for heart
failure
Prospective cohort
study
Implemented a heart failure
“bundle” that included
inpatient heart failure
education, a home visit
within 48 h of discharge, a
follow-up appointment
with a physician and a
follow-up phone call from a
heart failure care manager
within 7 days of discharge.
Readmissions rates were
reduced from 19 to 15 %
over 30-days (p = 0.03).
In-hospital clinical audits/registries/quality improvement initiatives
Boutwell,
2011 [33]
(State Action on Avoidable
Rehospitalizations
initiative- STAAR
program)
148 hospitals throughout the US Quality improvement
program.
Hospitals work in
partnership with providers
and community services
that the hospital frequently
uses to collaborate in
improving communication
and coordination during
transition from the hospital
to the next setting of care.
No results published to date
Heidenreich
2012 [26]
(GWTG-HF
program)
over 5 million patients and
over 2093 US hospitals
participate at least once in
GWTG throughout the US
Quality improvement
program.
Registered hospitals receive
access to GWTG toolkit
specific for heart failure.
The toolkit comprises of:
initiation of evidence-based
medications, implantation
of appropriate device
therapies, discharge
education about heart
failure, evaluation of left
ventricular function, and post
discharge follow-up
appointment. Data is then
entered into a web based
system and each
participating hospital
receives site level patient
data to identify those at risk
of readmission.
Hospitals participating in
GWTG-HF had significantly
higher documentation of
the left ventricular ejection
fraction (93.4 % versus non-
participating hospitals
(89 %), use of ACEI or
angiotensin receptor
antagonist (88.3 % versus
86.6 %), and discharge
instructions (74.9 % versus
70.5 %).
After discharge, all-cause
readmission at 30 days was
24.5 % and mortality at
30 days after admission
was 11.1 %.
30-day readmission was
lower for GWTG hospitals
(−0.33 %; 95 % CI, −0.53 %
to −0.12 %).
Hansen, 2013 [32]
BOOST program
11 hospitals throughout the
US. In Feb 2014, 180 hospitals
were participating.
Patient numbers are not
mentioned
Quality improvement
program. Pre and post
implementation design.
The BOOST intervention
consisted of a toolkit which
contained: an
implementation guide,
project management tools,
such as the Teach Back
Training Curriculum, and
PICO guidelines to evaluate
the intervention; face‐to‐
face training and
12 months of expert
mentoring and coaching
and assistance to build a
culture that supports
organisational change to
reduce hospital
readmissions, also linking
The average rate of 30-day
rehospitalization prior to
implementation was 15 %
and 13 % 12 months later.
This was an absolute
reduction of 2 % and a
relative reduction of 14 %.
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Table 4 Included studies of systems of care for heart failure (excluding systematic reviews, meta-analyses and policy documents)
(Continued)
with other participating
sites and data
management. Each site also
received project benchmark
data and site level patient
data.
H2H National
Quality Improvement
Initiative, 2015
[34] (H2H
program)
No data available Quality improvement
program.
The Hospital to Home
(H2H) Initiative provides a
toolkit to clinicians assist
them in implementing
evidence-based care from
clinical guidelines, within
their organisation.
No data available
Transitional care
Jaarsma, 2008 [44] 1023 patients were enrolled
post hospitalisation for ADHF.
Patients were assigned to 1 of
3 groups: a usual care group, a
HF nurse follow-up
post-discharge
and intensive support by
a HF nurse.
RCT The usual care group
consisted of follow-up with
a Cardiologist within two
months post-discharge and
then six monthly.
Patients in group 2 had
nine clinic visits with a HF
nurse post-discharge, in
addition to the usual care
visits. Education about HF
and self-management
strategies were provided
during the HF nurse clinic
visits.
Group 3 received the same
visits as Group 2 and then
also received one home
visit and weekly telephone
contact during the first
month post-discharge. After
the first month, they also
received two additional
home visits and two visits
with the multidisciplinary
team.
All patients were follow up
for 18 months.
Neither moderate nor
intensive follow up by a HF
nurse reduced the
combined end points of HF
death and hospitalization
compared with usual care.
At 18 months, 411 patients
(40 %) were readmitted
because of HF or died from
any cause: 42 % in the
control group, and 41 %
and 38 % in the basic and
intensive support groups,
respectively (hazard ratio,
0.96 and 0.93, respectively;
P = .73 and P = .52,
respectively).
All-cause mortality occurred
in 29 % of patients in the
control group, and there
was a trend toward lower
mortality in the intervention
groups combined (P = .18).
Driscoll, 2011 [45] Thirty-three community-based
heart failure program
coordinators recruited 484
patients diagnosed with
systolic dysfunction and
>1 earlier hospitalization
for ADHF
Cohort study. All
patients were
followed up for six
months.
Patient outcomes in
programs with nurse-led
titration (NLT) of beta-
blockers were compared
with those in programs that
did not allow such titration.
At 6 months, 47 % of
patients participating in UC
programs had no change
in dosage from baseline to
6 months, compared with
39 % of patients
participating in NLT
programs. Patients in NLT
programs were also more
likely to be prescribed at
target dose (48 % NLT vs
36 % UC). The composite
of all-cause hospitalizations
and mortality was lower in
patients participating in
programs allowing NLT (HR
0.58, 95 % CI 0.42–0.81).
Outpatient clinics
Fonarow,
2011 [51]
IMPROVE program
15,381 patients with HFrEF
from 167 US outpatient
cardiology practices
Prospective clinical
registry
No invention as it was a
clinical registry
Adherence to a range of
guideline-recommended
heart failure therapies
ranging from 30–80 %. An
increase in adherence in
performance measures was
significantly associated with
improved survival
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(Continued)
Driscoll, 2014 [46] 13 patients diagnosed with
HFrEF were randomised to
usual care and 12 to the NLT
clinic
RCT Patients were randomised
to optimisation of BB in a
nurse-led titration (NLT)
clinic, led by a nurse
specialist with the support
of a cardiologist in a heart
failure clinic, or by their
primary care physician
The time to maximum
dose was shorter in the
NLT group compared to
the UC group (90 ± 14 vs
166 ± 8 days, p < 0.0005). At
six months, in the NLT
group there were 82 % on
high dose and 9 % on low
dose beta-adrenergic
receptor blocker compared
to the UC group with 42 %
patients reaching
maximum dose and 42 %
patients on low dose.
Fenner, 2014 [50] Patients admitted to hospital
with ADHF.
No data was available. Patients were seen in
hospital and given
education by a heart failure
nurse. Patients had an
appointment scheduled
within three days post-
discharge to attend the
Heart Success Transition
Clinic (HSTC). They were
seen in the clinic for 4–6
weeks and then referred
back to primary care.
A telemedicine clinic was
also available for patients
living in rural and remote
areas.
HSTC found a reduction in
heart failure readmission
rate from 17.92 % to
13.49 %. The telemedicine
clinic reduced heart failure
readmissions from 18 % to
10 % over a six month
period
Telemonitoring programs
Piette, 2008 [60] 52 heart failure patients and
their carers
Prospective cohort
study
Telemonitoring using
informal carers. The
CarePartner Program
included an automated
telephonic heart failure
assessment and behaviour
change service.
Patients received weekly
calls from the system and
reported information about
their health and self-care
using their touchtone
telephone.
Care nurse managers were
notified when a patient
reported an urgent medical
condition.
75 % of patients had made
changes in their self-care as
a result of the intervention.
Schwarz,
2008 [59]
102 patients and their carers
post discharge from hospital
with ADHF
RCT
90 day follow-up
Participants were
interviewed within 10 days
post discharge and 90 days
later. The patient recorded
their weight and vital signs
daily via the telemonitoring
system and responded to
questions about symptoms.
The data from the
telemonitoring system was
monitored daily by a heart
failure nurse.
Usual care consisted of
follow-up with their
primary physician or
cardiologist.
No significant difference in
hospital readmissions or
mortality
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(Continued)
Woodend,
2008 [57]
121 patients admitted with HF
and 128 patients admitted
with angina
RCT
90 day follow-up
The telemonitoring system
consisted of video
conferencing and phone
transmission of weight, vital
signs and ECG. The patient
was required to record
their weight and vital signs
via the telemonitoring
system daily and weekly
video conferencing with
the heart failure nurse.
Usual care consisted of
follow-up with their
primary physician or
cardiologist.
No significant difference in
hospital readmissions or
mortality for heart failure
patients
Chaudhry,
2010 [55]
1653 patients admitted with
ADHF
RCT The telemonitoring group
was instructed to make
daily, toll-free calls to the
system. During each call,
patients heard a series of
questions about general
health and heart-failure
symptoms.
The protocol required the
sites to contact any patient
whose response generated
an alert.
No significant difference in
hospital readmissions or
mortality
Koehler, 2011 [52] 710 chronic heart failure
patients
RCT The telemonitoring
program consisted of:
portable devices for ECG,
blood pressure, and body
weight measurements.
Patients were required to
undertake daily self-
assessments and the data
was transferred to the
telemonitoring data centre.
Usual care consisted of
follow-up with their
primary physician or
cardiologist.
No difference in mortality
or heart failure
hospitalisations between
groups.
Angermann,
2012 [39]
715 patients hospitalised with
systolic heart failure
RCT
All patients were
followed up for
180 days.
The telemonitoring
intervention consisted of:
inhospital visit, structured
telephone follow-up
addressing heart failure
symptoms, medications,
health systems utilisation
and psychological well-
being; titration of heart
failure medication, and
increased access to
specialist care. Contact was
weekly for one month and
then individualised based
on NYHA class.
Usual care consisted of
follow-up with their
primary physician or
cardiologist.
No difference in mortality
or hospitalisations between
groups.
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Table 4 Included studies of systems of care for heart failure (excluding systematic reviews, meta-analyses and policy documents)
(Continued)
Dendale,
2012 [54]
160 patients hospitalised with
ADHF from seven hospitals
RCT
Six month follow up
Patients were asked to
transmit their weigh and
vital signs daily via the
telemonitoring system.
When these measurements
exceeded preset limits for
two consecutive days an
automatic email alert was
sent to their primary
physician and heart failure
clinic. Their primary
physician was to contact
the patient when they
received an alert and the
heart failure nurse would
follow up with the patient
1–3 days post alert.
Usual care and
telemonitoring patients
were all seen in the heart
failure clinic 2 weeks
post-discharge.
Usual care consisted of
follow-up with their
primary physician
post-discharge.
All-cause mortality was
significantly lower in the
TM group as compared
with the UC group (5 % vs.
17.5 %, P = 0.01).
The number of heart failure
readmissions per patient
showed a trend (0.24 vs.
0.42 hospitalizations/
patient, P = 0.06) in favour
of TM.
Pekmezaris,
2012 [56]
168 patients hospitalised with
a primary or secondary
diagnosis of heart failure
RCT
All patients were
followed up for
90 days.
The telehealth intervention
consisted of two video-
based nursing visits
(including weighs and
monitoring of vital signs)
and one visit with a
community heart failure
nurse within the first two
weeks post-discharge. The
frequency of the telehealth
visits was determined the
heart failure nurse based
on patient needs and
continued for 90 days
post-discharge.
Usual care consisted of
follow-up with a
community heart failure
nurse.
No significant difference in
hospital readmissions or
mortality
Baker, 2013 [61] 3534 patients with chronic
heart failure, chronic
obstructive pulmonary disease,
or diabetes mellitus.
Intervention group (n = 1,767)
and in the matched control group
(n = 1,767)
Retrospective
matched cohort study.
Two years of follow-up
The Health Buddy Program,
which integrated a
content-driven telehealth
system with care
management.
The Health Buddy Program
had 15 % lower risk-
adjusted all-cause mortality
(HR 0.85, 95 % CI 0.74–0.98)
and reductions in inpatient
readmissions during the
study period that were
18 % greater than those of
matched controls during
this same time period
(−0.035 vs −0.003;
difference-in-differences =
−0.032, 95 % CI = −0.054
to −0.010).
Krum, 2013 [53]
CHAT study
405 patients diagnosed with
heart failure. 217 patients were
randomised to usual care by
their primary physican and 188
to the intervention group.
Cluster deign trial with
randomisation at level
of General Practitioner.
All patients were
followed up for
12 months
The intervention comprised
of ongoing support by
touchtone telephone using
the ‘TeleWatch’ system.
Patients were required to
dial in monthly to receive
advice about the
management of their heart
Fewer patients hospitalised
for any cause (74 versus
114, adjusted HR 0.67, 95 %
CI 0.50–0.89) and who died
or were hospitalised (89
versus 124, adjusted HR
0.70 (95 % CI 0.53–0.92), in
the intervention group vs
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